Vertex Pharmaceuticals (VRTX) Times Interest Earned (2009 - 2025)
Vertex Pharmaceuticals' quarterly Times Interest Earned came in at $365.42 in Q4 2025, little changed year-on-year from $366.43 in Q4 2024, and up 1.66% quarter-over-quarter from $359.45 in Q3 2025.
Vertex Pharmaceuticals has reported Times Interest Earned for 10 years, with the latest figure at $365.42 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned changed 0.27% year-over-year to $365.42; the trailing twelve-month figure through Mar 2026 stood at $454.5 (up 1520.49% YoY), and the FY2025 full-year result was $313.78, up 4222.68% from the prior year.
- Times Interest Earned for Q4 2025 stood at $365.42, up from $359.45 in the prior quarter.
- The five-year high for Times Interest Earned was $366.43 in Q4 2024, with the low at -$355.02 in Q2 2024.
- Average Times Interest Earned over 3 years is $163.27, with a median of $148.84 recorded in 2024.
- Peak annual rise in Times Interest Earned reached 292.93% in 2024, while the deepest fall reached 487.4% in 2024.
- Tracing VRTX's Times Interest Earned over 3 years: stood at $93.25 in 2023, then surged by 292.93% to $366.43 in 2024, then retreated by 0.27% to $365.42 in 2025.
- The last three Times Interest Earned figures came in at $365.42 (Q4 2025), $359.45 (Q3 2025), and $311.11 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -36.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 365.42 |
| Sep 30, 2025 | 359.45 |
| Jun 30, 2025 | 311.11 |
| Mar 31, 2025 | 210.03 |
| Dec 31, 2024 | 366.43 |
| Sep 30, 2024 | 148.84 |
| Jun 30, 2024 | -355.02 |
| Mar 31, 2024 | 109.57 |
| Dec 31, 2023 | 93.25 |
| Sep 30, 2023 | 95.24 |
| Jun 30, 2023 | 91.64 |
| Dec 31, 2020 | 45.79 |
| Sep 30, 2020 | 48.52 |
| Jun 30, 2020 | 51.77 |
| Mar 31, 2020 | 50.95 |
| Dec 31, 2019 | 38.70 |
| Sep 30, 2019 | 6.83 |
| Jun 30, 2019 | 18.20 |
| Mar 31, 2019 | 18.62 |
| Dec 31, 2018 | 6.81 |
| Sep 30, 2018 | 11.01 |
| Jun 30, 2018 | 9.52 |
| Mar 31, 2018 | 7.63 |
| Dec 31, 2012 | -20.43 |
| Sep 30, 2012 | -0.23 |
| Jun 30, 2012 | -2.57 |
| Mar 31, 2012 | 22.33 |
| Dec 31, 2011 | 18.01 |
| Sep 30, 2011 | 30.56 |
| Mar 31, 2011 | -13.32 |
| Dec 31, 2010 | -21.68 |
| Sep 30, 2010 | -50.52 |
| Jun 30, 2010 | -46.04 |
| Mar 31, 2010 | -40.53 |
| Dec 31, 2009 | -32.16 |
| Sep 30, 2009 | -76.92 |
| Jun 30, 2009 | -47.27 |
| Mar 31, 2009 | -47.93 |